返回
刘
刘华 (Hua Liu)
central hospital
49H指数
468论文数
1.4W被引数
收录论文 140
发表时间
Corrigendum to “Rapid molecular diagnostic method for Gardnerella vaginalis based on CRISPR-Cas12a and recombinase-aided amplification (RAA)” [Clin. Chim. Acta 579 (2025) 120625]勘误:基于CRISPR-Cas12a和重组酶辅助扩增(RAA)的加德纳菌(Gardnerella vaginalis)快速分子诊断方法 [Clin. Chim. Acta 579 (2025) 120625]
Clinica Chimica Acta
IF2.9
A randomized, controlled, multicenter phase III study of IBI310 (anti-CTLA-4 antibody) plus sintilimab (anti-PD-1 antibody) as neoadjuvant treatment for resectable microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) colon cancer一项随机、对照、多中心III期研究,评估IBI310(anti-CTLA-4 antibody)联合sintilimab(anti-PD-1 antibody)作为可切除微卫星高度不稳定/错配修复缺陷(MSI-H/dMMR)结肠癌的新辅助治疗方案。
ANNALS OF ONCOLOGY
IF65.4

